Evidence map›Paper›PMID 30052120›Full record

ArticleVirulence2018

Eicosanoid biosynthesis influences the virulence of Candida parapsilosis.

Tanmoy Chakraborty, Ernst Thuer, Marieke Heijink, Renáta Tóth, László Bodai, Csaba Vágvölgyi, Martin Giera, Toni Gabaldón, Attila Gácser

Open access · goldAbstract read
In one paragraph

Article in Virulence, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. The role ofMicrobiology spectrum · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Host/Metabolites · 2021
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Multicopper Oxidases inJournal of fungi (Basel, Switzerland) · 2020
    Review
  13. Review
  14. Eicosanoid production byVirulence · 2019
    Review
  15. Article
  16. Review
  17. Candida parapsilosis: from Genes to the Bedside.Clinical microbiology reviews · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Tanmoy Chakrabortya Department of Microbiology , University of Szeged , Szeged , Hungary.
Ernst Thuerb Centre for Genomic Regulation (CRG) , Barcelona Institute of Science and Technology , Barcelona , Spain.
Marieke Heijinkd Center for Proteomics and Metabolomics , Leiden University Medical Center , Leiden , The Netherlands.
Renáta Tótha Department of Microbiology , University of Szeged , Szeged , Hungary.
László Bodaie Department of Biochemistry and Molecular Biology , University of Szeged , Szeged , Hungary.
Csaba Vágvölgyia Department of Microbiology , University of Szeged , Szeged , Hungary.
Martin Gierad Center for Proteomics and Metabolomics , Leiden University Medical Center , Leiden , The Netherlands.
Toni Gabaldónb Centre for Genomic Regulation (CRG) , Barcelona Institute of Science and Technology , Barcelona , Spain.
Attila Gácsera Department of Microbiology , University of Szeged , Szeged , Hungary.ORCID 0000-0003-2939-9580
University of Szeged · HULeiden University Medical Center · NLInstitució Catalana de Recerca i Estudis Avançats · ESUniversitat Pompeu Fabra · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipid mediators, derived from arachidonic acid metabolism, play an important role in immune regulation. The functions of bioactive eicosanoids range from modulating cytokine signaling and inflammasome formation to anti-inflammatory and pro-resolving activities. Human pathogenic fungi such as Candida albicans, Candida parapsilosis, Cryptococcus neoformans and Aspergillus fumigatus have been shown to produce such lipid mediators, associated with their virulence. To date, investigations into the molecular mechanisms of fungal eicosanoid biosynthesis in different species have revealed that several genes are associated with prostaglandin production. However, these routes remain uncharacterized in C. parapsilosis with early results suggesting it uses pathways distinct from those found in C. albicans. Therefore, we aimed to identify and characterize C. parapsilosis genes involved in eicosanoid biosynthesis. Following arachidonic acid treatment of C. parapsilosis cells, we identified several genes interfering with prostaglandin production. Out of the identified genes, homologues of a multi copper oxidase (FET3), an Acyl-CoA thiolase (POT1) and an Acyl-CoA oxidase (POX1-3) were found to play a significant role in prostaglandin synthesis. Furthermore, all three genes were confirmed to enhance C. parapsilosis pathogenicity, as the corresponding deletion mutants were cleared more efficiently by human macrophages and induced higher levels of pro-inflammatory cytokines. In addition, the mutants were less virulent than the wild-type strain in a mouse model of systemic infection. Taken together, we identified three genes that regulate eicosanoid biosynthesis in C. parapsilosis and impact the fungus' virulence.

Indexed as

Acyl-CoA OxidaseAnimalsBiosynthetic PathwaysCandida parapsilosisCandidiasisCoenzyme A-TransferasesEicosanoidsFemaleFungal ProteinsHumansMiceMice, Inbred BALB COxidoreductasesVirulenceAcyl-CoA Oxidaseacyl-CoA transferaseCoenzyme A-Transferasescopper oxidaseEicosanoidsFungal ProteinsOxidoreductasesCandida parapsilosisfungal eicosanoidshost-pathogen interactionimmunomodulationvirulence

Identifiers

PMID30052120
PMCPMC6086292
OpenAlexW2884216576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.